World's Best Scientists 2026 revealed!
Andrew J. McLachlan

Andrew J. McLachlan

D-Index & Metrics

Medicine

D-Index
82
Citations
24655
World Ranking
16117
National Ranking
533

Andrew J. McLachlan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Andrew J. McLachlan sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 495 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Andrew J. McLachlan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew J. McLachlan sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Andrew J. McLachlan is affiliated with the University of Sydney in Australia and has an extensive publication record primarily in the field of Medicine, with a strong focus on Pharmacology and related subfields. Their research covers diverse areas including Public Health, Environmental and Occupational Health, Economics and Econometrics, Geriatrics and Gerontology, and Surgery.

The main topics addressed in their work include:

  • Musculoskeletal pain and rehabilitation
  • Pharmaceutical Practices and Patient Outcomes
  • Health Systems, Economic Evaluations, Quality of Life
  • Pain Management and Opioid Use
  • Opioid Use Disorder Treatment
  • Anesthesia and Pain Management
  • Chronic Myeloid Leukemia Treatments

Andrew J. McLachlan has published multiple papers in notable venues. Frequent publication venues include the British Journal of Clinical Pharmacology with 11 papers, BMJ Open with 6 publications, BMJ with 5 publications, Drugs & Aging with 4, and Trials with 4.

Some recent papers authored or coauthored by McLachlan are:

  • Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis (2021, BMJ)
  • Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy (2020, The Annual Review of Pharmacology and Toxicology)
  • Opioid analgesia for acute low back pain and neck pain (the OPAL trial): a randomised placebo-controlled trial (2023, The Lancet)
  • Epidural corticosteroid injections for lumbosacral radicular pain (2020, Cochrane Database of Systematic Reviews)
  • The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews (2021, The Medical Journal of Australia)

Frequent co-authors include:

  • Christopher G. Maher
  • Christina Abdel Shaheed
  • Chung-Wei Christine Lin
  • Richard O. Day
  • Stephanie Mathieson

The research contributions of Andrew J. McLachlan emphasize both clinical and pharmacological aspects of pain management, medication safety, and individualized drug therapy approaches. Their work intersects clinical trials, systematic reviews, and health system evaluations, addressing issues relevant to the management and outcomes of musculoskeletal conditions, opioid use, and related pharmaceutical practices.

Best Publications

  • Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

    Danijela Gnjidic;Sarah N. Hilmer;Sarah N. Hilmer;Fiona M. Blyth;Fiona M. Blyth;Vasi Naganathan;Vasi Naganathan

  • Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.

    Gustavo C. Machado;Chris G. Maher;Paulo H. Ferreira;Marina B. Pinheiro

  • Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

    Nicole Lowres;Lis Neubeck;Glenn P Salkeld;Ines Krass

  • Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.

    Neal M. Davies;Andrew J. McLachlan;Ric O. Day;Kenneth M. Williams

  • Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis

    Alemayehu B Mekonnen;Andrew J McLachlan;Jo-anne E Brien

  • Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis

    Christina Abdel Shaheed;Christina Abdel Shaheed;Chris G. Maher;Chris G. Maher;Kylie A. Williams;Richard O. Day

  • Medication withdrawal trials in people aged 65 years and older: a systematic review.

    Shoba Iyer;Vasi Naganathan;Andrew J McLachlan;David G Le Couteur

  • Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

    Xuemin Jiang;Kenneth M. Williams;Winston S. Liauw;Alaina J. Ammit

  • Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial.

    Christopher M. Williams;Christopher M. Williams;Christopher G. Maher;Jane Latimer;Andrew J. McLachlan

  • Clinical pharmacology in the geriatric patient.

    Sarah N. Hilmer;Andrew J. McLachlan;David G. Le Couteur

  • Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring

    Michael J. Dolton;John E. Ray;Sharon C.-A. Chen;Kingsley Ng

  • High-Risk Prescribing and Incidence of Frailty Among Older Community-Dwelling Men

    Donijela Gnjidic;Sarah Hilmer;Sarah Hilmer;Fiona Blyth;Fiona Blyth;Vasin Naganathan;Vasin Naganathan

  • Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis.

    Rafael Zambelli Pinto;Chris G. Maher;Manuela L. Ferreira;Mark Hancock

  • Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.

    Alemayehu B. Mekonnen;Alemayehu B. Mekonnen;Andrew J. McLachlan;Andrew J. McLachlan;Jo-anne E. Brien;Jo-anne E. Brien

  • Too much medicine in older people? Deprescribing through shared decision making

    Jesse Jansen;Vasi Naganathan;Stacy L Carter;Andrew J McLachlan

  • Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

    Xuemin Jiang;Kenneth M. Williams;Winston S. Liauw;Alaina J. Ammit

  • Low Back Pain and Best Practice Care: A Survey of General Practice Physicians

    Christopher M. Williams;Christopher G. Maher;Mark J. Hancock;James H. McAuley

  • Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial

    Mark J Hancock;Christopher G Maher;Jane Latimer;Andrew J McLachlan

  • Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment

    Andrew J. McLachlan;Andrew J. McLachlan;Sally Bath;Vasi Naganathan;Vasi Naganathan;Sarah N. Hilmer;Sarah N. Hilmer

  • Drugs for relief of pain in patients with sciatica: systematic review and meta-analysis

    Rafael Zambelli Pinto;Christopher G Maher;Manuela L Ferreira;Paulo H Ferreira

Frequent Co-Authors

Christopher G. Maher
Christopher G. Maher University of Sydney
Richard O. Day
Richard O. Day University of New South Wales
Sarah N. Hilmer
Sarah N. Hilmer University of Sydney
David G. Le Couteur
David G. Le Couteur University of Sydney
Manuela L. Ferreira
Manuela L. Ferreira University of Sydney
Stephen J. Clarke
Stephen J. Clarke University of Sydney
Fiona M. Blyth
Fiona M. Blyth University of Sydney
Bart W. Koes
Bart W. Koes Erasmus University Rotterdam
David J. Hunter
David J. Hunter Harvard University
Basil D. Roufogalis
Basil D. Roufogalis University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA extends beyond traditional medical school. There are affordable and flexible online options for those interested in healthcare roles that don't require a full MD program.

For example, those looking to enter healthcare administration can start with the cheapest medical coding certification online. This pathway is ideal for individuals who want to work with medical records and billing processes, and certification can be a valuable credential for entry-level positions.

Prospective nurses can choose from the most reputable online nursing school options, offering flexibility for both undergraduate and RN-to-BSN programs. Those seeking advanced practice roles can look into the cheapest np school online to become nurse practitioners.

For nursing professionals aiming for academic or research careers, pursuing a phd in nursing online opens further opportunities. These affordable online degrees allow you to balance personal and professional commitments while advancing your medical career.

Best Scientists Citing Andrew J. McLachlan

Trending Scientists

Recently Published Articles